Patients With Residual or Reccurent EGFRvIII+ Glioma
1 clinical trials · Condition
◉ Watch Patients With Residual or Reccurent EGFRvIII+ Glioma
| Record | Firm | Date |
|---|---|---|
| Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma (NCT02209376) | University of Pennsylvania | 2014-11-18 |
Track Patients With Residual or Reccurent EGFRvIII+ Glioma automatically
Every clearance here is in the API, with alerts when new ones post.